To tackle America’s gun problem, a growing number of states are using Medicaid dollars to pay for community-based programs intended to stop shootings.
Edgewise boosts awareness of rare Becker muscular dystrophy as it pursues potential first therapy
As Edgewise Therapeutics works towards its first FDA drug approval, the small biopharma is already launching resources for one of the rare disease communities it
December 30, 2023